Search results
MGI and SeqOne partner to create end-to-end genomic testing platform
Medical Device Network via Yahoo Finance· 4 days agoThe companies aim to create an end-to-end solution for homologous recombination deficiency (HRD)...
EDX Medical launches cancer heredity diagnostic tool
Medical Device Network via Yahoo Finance· 23 hours ago"This test enables doctors to identify important genetic risks shared by patients and their families, to take...decisions and ensure access to modern...
NHS genomics testing will be vital in supporting personalised cancer trials
Clinical Trials Arena via Yahoo Finance· 7 days ago“We funded an infrastructure to support innovation, and alignment with research and development and...
Reveal Genomics launches HER2+ breast cancer diagnostics trial
Medical Device Network via Yahoo Finance· 3 days agoSpanish biotech start-up, Reveal Genomics, has announced the launch of a trial evaluating the...
German Precision Medicine Model Project Gets Ready for Kickoff as Commercial Providers Cry Foul
GenomeWeb News· 19 hours agoLong in preparation, it plans to test the feasibility and utility of decentralized genomic testing in medical care across the country, while collecting ...
Tempus rises 9% on the first day of trading, demonstrating investor appetite for a health tech with...
TechCrunch· 7 days agoTempus, a genomic testing and data analysis company started by Eric Lefkofsky, who previously...
Hawaii-developed COVID home test kits being sold online
Honolulu Star-Advertiser· 3 days agoA locally developed COVID-19 test kit is now on the market as cases of the contagious disease are on...
Newswise Expert | Debora Bruno, Case Western Reserve University
Newswise· 4 days agoDr. Bruno is a medical oncologist and clinical researcher with a focus on lung cancer and other thoracic malignancies such as thymomas/thymic carcinomas as well as mesothelioma ...
Tempus AI shares jump 8% in strong Nasdaq debut as US IPO market thaws
Reuters via Yahoo Finance· 7 days agoTempus' customers include major drugmakers such as AstraZeneca and GSK. It competes with Swiss...
Study reveals novel immune-based biomarker helps detect ovarian cancer years before conventional...
Medical Xpress· 7 days agoResearchers at Children's Hospital of Philadelphia (CHOP) announced the discovery of a novel immune-based biomarker that could pave the way for potential lifesaving early detection of high-grade ...
